• Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2
  • Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2
  • Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2
  • Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2
  • Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2
  • Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2

Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2

Powder: Yes
Customized: Customized
Certification: GMP, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Powder
Purity: >99%
Samples:
US$ 10/grams 1 grams(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5

Basic Info.

Model NO.
TGY-0692 Cabazitaxel
Product Name
Cabazitaxel Powder
Appearance
White Powder
CAS No.
183133-96-2
Molecular Formula
C45h57no14
Molecular Weight
835.93
Assay
99%
COA
Available
Sample
Available
MOQ
Any Quantitiy
Service
OEM
Grade
Pharmaceutical Grade
Test Method
USP; GMP
Storage
Cool Dry Area
Shelf Life
24 Months Properly
Certificate
ISO9001:2008
Transport Package
Boil Bag
Specification
HPLC 99%
Trademark
TGY
Origin
Xi′an, Shaanxi, China (Mainland)
HS Code
29225090
Production Capacity
5000kg/Month

Product Description

Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2

Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2
Cabazitaxel (previously XRP-6258) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

Cabazitaxel in combination with prednison is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment.

Cabazitaxel anticancer mechanism and characteristics similar with docetaxel, belongs to anti-microtubule drugs. Cabazitaxel through binding to tubulin, promoting their assembly into microtubules, and can prevent these have assembled a microtubule disintegration of the stabilization of microtubules, thereby inhibiting cell mitosis, and interphase cellular functions (interphasecellularfunctions) of play.
Product Name Cabazitaxel
CAS 183133-96-2
Appearance Off-White Powder
Molecular formula C45H57NO14
Molecular Weight 835.93
Assay 99%
Shelf Life 24 months when properly stored
Storage Keep in a cool, dry, dark location

Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2

1.Cabazitaxel anticancer mechanism and characteristics similar with docetaxel, belongs to anti-microtubule drugs.
2.Cabazitaxel through binding to tubulin, promoting their assembly into microtubules,
3.It can prevent these have assembled a microtubule disintegration of the stabilization of microtubules, thereby
inhibiting cell mitosis, and interphase cellular functions (interphasecellularfunctions) of play.


Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2Cabazitaxel's anti-cancer mechanism and characteristics are similar to docetaxel and belong to anti-microtubule drugs. Cabazitaxel promotes its assembly into microtubules by binding to tubulin, while preventing the disassembly of these assembled microtubules, stabilizing microtubules, thereby inhibiting cell mitosis, and interphase cellular functions.

 

Factory Supply Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5
Terms of Payment
LC, T/T, D/P, PayPal, Western Union, Small-amount payment
International Commercial Terms(Incoterms)
FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW, Others